Back to Results

Milestone Scientific (MLSS)

Milestone Scientific Inc. is a healthcare company focused on biomedical technology for diagnostic and therapeutic injection applications. The company develops and commercializes devices used in medical and dental settings across the United States, China, and other international markets. Its operations are organized into Dental and Medical segments. In dental care, Milestone Scientific markets the Wand, a disposable handpiece used for procedures requiring local anesthetic, and related systems such as CompuDent and STA Single Tooth Anesthesia System. In medical applications, its product line includes CompuFlo, a computer-controlled drug delivery system, along with a disposable injection handpiece designed to support tactile control during administration. The company also provides CompuFlo Epidural and CompuMed for use in a range of medical specialties. Founded in 1989, Milestone Scientific is headquartered in Roseland, New Jersey.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-MLSS
$0.36
-10.6% Downside
Fair
$1.25
214.7% Upside
Bargain
Fair
0.0%
November 12, 2026
10.2x
3.7x
35.247 M
33.796 M
1.7%
84.4%
-18.6
15.9%
Valuation • Fair Value

Milestone Scientific (NYSE-MLSS) Fair Value by Valuation Model

Review the available estimates for Milestone Scientific (NYSE-MLSS), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.36

Estimated downside of 10.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.35

Discounted cash flow valuation reference.

EPV Fair Value

$0.25

Earnings power value estimate.

Comps Fair Value

$0.38

Comparable-company valuation reference.

Analyst Price Target

$1.25

Analysts imply upside of 214.7%.

How to read these valuation models

Use the 6 available valuation references for Milestone Scientific (NYSE-MLSS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Milestone Scientific (NYSE-MLSS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

9.421 M

Current operating scale indicator.

Revenue Forecast

9.974 M

Forward revenue estimate.

EBITDA

-4.025 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Milestone Scientific (NYSE-MLSS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Milestone Scientific (NYSE-MLSS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-4.23

No elevated caution signal from this screen.

Altman Z-Score

-18.6

Lower score that deserves closer risk review.

FCF / Net Income

15.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Milestone Scientific (NYSE-MLSS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Milestone Scientific (NYSE-MLSS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 12, 2026

Days to Earnings

51

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Milestone Scientific (NYSE-MLSS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Milestone Scientific (NYSE-MLSS) Stock Forecast & Technical Outlook

Review Milestone Scientific (NYSE-MLSS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Milestone Scientific (NYSE-MLSS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Milestone Scientific (NYSE-MLSS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Milestone Scientific (NYSE-MLSS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Milestone Scientific (NYSE-MLSS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Milestone Scientific (NYSE-MLSS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Milestone Scientific (NYSE-MLSS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Milestone Scientific (NYSE-MLSS) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Milestone Scientific (NYSE-MLSS) Stock FAQ

Data-supported answers about Milestone Scientific (NYSE-MLSS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.36
Estimated downside 10.6%
Valuation Rating
Overvalued
Estimated downside of 10.6%
Analyst Target
$1.25
Implied upside 214.7%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Milestone Scientific (NYSE-MLSS) is $0.36. This implies an estimated downside of 10.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 10.6% versus the current market price.

The available analyst price target for Milestone Scientific (NYSE-MLSS) is $1.25. The analyst target implies estimated upside of 214.7%.

The current financial health read for Milestone Scientific (NYSE-MLSS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Milestone Scientific (NYSE-MLSS) is November 12, 2026.

The latest available data indicates no current dividend yield for Milestone Scientific (NYSE-MLSS).

The current market capitalization listed for Milestone Scientific is 35.247 M.

The current enterprise value listed for Milestone Scientific is 33.796 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Milestone Scientific is NYSE-MLSS, and the stock is listed on NYSE.

Milestone Scientific (NYSE-MLSS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Milestone Scientific is 1.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Milestone Scientific is 84.4%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 142 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.1 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 65.099 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.173 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.847 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.185 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 41.084 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 33.785 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 31.756 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.674 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 29.933 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.452 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 20.357 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 17.926 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.107 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.581 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 12.242 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.566 B